Prosperitas Financial
ABBV icon

Prosperitas Financial’s AbbVie ABBV Stock Holding History

Prosperitas Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.27M Buy
23,977
+1,663
+7% +$426K 1.89% 17
2026
Q2 		$5.62M Buy
22,314
+2,650
+13% +$570K 1.8% 19
2026
Q1 		$4.28M Buy
19,664
+1,062
+6% +$236K 1.59% 27
2025
Q4 		$4.25M Buy
18,602
+480
+3% +$109K 1.65% 22
2025
Q3 		$4.2M Buy
18,122
+816
+5% +$166K 1.74% 20
2025
Q2 		$3.21M Buy
17,306
+1,635
+10% +$304K 1.51% 25
2025
Q1 		$3.28M Buy
15,671
+876
+6% +$170K 1.7% 22
2024
Q4 		$2.63M Buy
14,795
+1,229
+9% +$226K 1.33% 29
2024
Q3 		$2.68M Buy
13,566
+885
+7% +$165K 1.44% 25
2024
Q2 		$2.18M Buy
12,681
+593
+5% +$98.2K 1.33% 26
2024
Q1 		$2.2M Buy
12,088
+1,038
+9% +$179K 1.41% 23
2023
Q4 		$1.71M Buy
11,050
+1,243
+13% +$181K 1.26% 25
2023
Q3 		$1.46M Buy
+9,807
New +$1.44M 1.14% 24

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return

Prosperitas Financial's ABBV Position: Q3 2026 in Review

Prosperitas Financial increased its AbbVie (ABBV) stake by 7.5% in Q3 2026, buying an estimated $426K and bringing the position to 23,977 shares worth $6.27M. The position accounts for 1.89% of the portfolio, ranked #17.

Prosperitas Financial first reported a position in ABBV in Q3 2023 and has held it in 13 quarters since. 3,064 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Prosperitas Financial held 23,977 shares of AbbVie worth $6.27M as of Q3 2026.
  • Prosperitas Financial bought 1,663 AbbVie shares in Q3 2026, an estimated $426K.
  • AbbVie made up 1.89% of Prosperitas Financial's portfolio in Q3 2026, its #17 holding.
  • Prosperitas Financial first reported a position in AbbVie in Q3 2023 and has held it in 13 quarters since.
  • 3,064 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Prosperitas Financial's 13F filing for Q3 2026, filed 28 Oct 2026.